This fact sheet introduces the IQVIA Biotech Master Protocol Unit (MPU), a specialized solution for managing complex adaptive clinical trials using master protocols. These trial designs allow multiple therapies to be tested within a single, flexible framework, improving efficiency and accelerating time to market. The MPU provides purpose-built infrastructure, specialized teams, and scalable processes to manage the complexity of multi-arm trials across their lifecycle. Key capabilities include flexible resourcing, continuous arm availability, proactive site engagement, cost transparency, and real-time data analysis. With experience spanning 100+ master protocol studies across dozens of countries, IQVIA enables sponsors to streamline operations, improve data integration, and enhance trial ex

Join for free to read